Collaborate negotiates important agreement with ORIX Australia


Published 28-FEB-2017 15:47 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Collaborate Corporation’s (ASX:CL8) DriveMyCar business has signed a strategic agreement with ORIX Australia Corporation Limited (ORIX) for ORIX vehicles to be rented through the DriveMyCar platform to private and corporate rental customers.

Established in 1986, the ORIX Group is the largest fleet management group in the Asia Pacific with over 1,100 offices and 800,000 assets valued at circa $1 billion under lease and management throughout the region.

ORIX Australia is part of the global ORIX Group specialising in the acquisition, financing and management of both motor and commercial vehicles.

DriveMyCar to manage marketing, rental bookings, payments and verification checks

The first vehicles will be made available in Sydney in March 2017, with launches in Melbourne and Brisbane to follow shortly thereafter. Under the agreement, DriveMyCar will manage marketing of the vehicles, rental bookings, payments and verification checks while ORIX will hand over the vehicles from their comprehensive network of offices around Australia.

With locations in key business centres in Macquarie Park in Sydney and Eagle Farm in Brisbane, the ORIX vehicles are expected to appeal to corporate customers seeking convenient access to reasonably priced quality rental vehicles.

DriveMyCar will specifically target corporate customers with a localised marketing campaign for the ORIX vehicles. ORIX will use the DriveMyCar inspection app to streamline vehicle handovers providing time savings for customers, DriveMyCar and ORIX.

What this will mean financially for CL8 remains to be seen, so investors should seek professional financial advice for further information if considering this stock for their portfolio.

Chris Noone, Collaborate Corporation CEO said “We are delighted to welcome ORIX as one of our key supply partners and are excited about the opportunity to target the corporate market with the range, quality and locations that match their needs”.

Reggie Cabal, CEO and Managing Director of ORIX commented “Working with one of Australia’s leading peer-to-peer rental businesses is a unique opportunity for us to transform the utilisation of our vehicles, and provide our superior range of fleet vehicles for private and corporate rental”.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free